drugset / Trial / NCT05031871

Pharmacokinetics of HR17031 Injection in Healthy Subjects

NCT05031871

Phase 1 Completed 24 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

To compare the pharmacokinetics and safety of HR17031 injection, SHR20004 injection and/or INS068 injection in healthy subjects

Timeline

Start
2021-09-02
Primary completion
2021-11-19
Completion
2021-11-19

Drugs

EvaluationDrugModalityDoseRoute
Subject HR17031 Unknown
Subject INS068 Protein / enzyme biologic
Subject SHR20004 Unknown